Magle Chemoswed Holding Ab (ST:MAGLE) — Market Cap & Net Worth
Market Cap & Net Worth: Magle Chemoswed Holding Ab (MAGLE)
Magle Chemoswed Holding Ab (ST:MAGLE) has a market capitalization of $866.66K (Skr8.05 Million) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #30780 globally and #717 in its home market, demonstrating a -0.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Magle Chemoswed Holding Ab's stock price Skr0.39 by its total outstanding shares 20649377 (20.65 Million). Also see how large is Magle Chemoswed Holding Ab's balance sheet for a full breakdown of the balance sheet.
Magle Chemoswed Holding Ab Market Cap History: 2020 to 2026
Magle Chemoswed Holding Ab's market capitalization history from 2020 to 2026. Data shows change from $102.11 Million to $866.66K (-46.98% CAGR). Also see MAGLE cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Magle Chemoswed Holding Ab is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.31 Billion | 0.01% | #242 of 281 |
Weight: Magle Chemoswed Holding Ab's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Magle Chemoswed Holding Ab Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Magle Chemoswed Holding Ab's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Magle Chemoswed Holding Ab (MAGLE) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.14x
Magle Chemoswed Holding Ab's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $102.11 Million | $142.34 Million | $1.82 Million | 0.72x | 56.14x |
| 2021 | $66.44 Million | $132.15 Million | $4.28 Million | 0.50x | 15.53x |
| 2022 | $59.56 Million | $145.68 Million | $9.14 Million | 0.41x | 6.51x |
| 2023 | $56.00 Million | $170.44 Million | $12.17 Million | 0.33x | 4.60x |
| 2024 | $77.33 Million | $236.04 Million | $11.94 Million | 0.33x | 6.48x |
| 2025 | $39.11 Million | $282.92 Million | -$159.88 Million | 0.14x | N/A |
Competitor Companies of MAGLE by Market Capitalization
Companies near Magle Chemoswed Holding Ab in the global market cap rankings as of September 19, 2026. Review tangible equity quality of Magle Chemoswed Holding Ab to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Magle Chemoswed Holding Ab by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Magle Chemoswed Holding Ab Historical Marketcap From 2020 to 2026
Between 2020 and today, Magle Chemoswed Holding Ab's market cap moved from $102.11 Million to $ 866.66K, with a yearly change of -46.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr866.66K | -97.78% |
| 2025 | Skr39.11 Million | -49.43% |
| 2024 | Skr77.33 Million | +38.10% |
| 2023 | Skr56.00 Million | -5.97% |
| 2022 | Skr59.56 Million | -10.37% |
| 2021 | Skr66.44 Million | -34.93% |
| 2020 | Skr102.11 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Magle Chemoswed Holding Ab was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $866.66K USD |
| MoneyControl | $866.66K USD |
| MarketWatch | $866.66K USD |
| marketcap.company | $866.66K USD |
| Reuters | $866.66K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Magle Chemoswed Holding Ab
Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride… Read more